Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:ENZ

Enzo Biochem (ENZ) Stock Price, News & Analysis

Enzo Biochem logo

About Enzo Biochem Stock (NYSE:ENZ)

Advanced Chart

Key Stats

Today's Range
$0.31
$0.40
50-Day Range
$0.33
$0.33
52-Week Range
$0.25
$1.19
Volume
4.12 million shs
Average Volume
173,401 shs
Market Capitalization
$17.03 million
P/E Ratio
N/A
Dividend Yield
123.08%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ENZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Enzo Biochem and its competitors with MarketBeat's FREE daily newsletter.

ENZ Stock News Headlines

ENZB - Enzo Biochem Inc Dividends - Morningstar
Elon Musk’s New Technology
Elon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a new AI supercomputer—what one industry CEO calls “the most powerful in the world.” Musk says this tech will drive the next wave of American innovation. You can’t invest in the supercomputer directly—but there’s a backdoor way to access the company powering it. It’s smaller than Tesla or Nvidia, but both rely on it for future growth.tc pixel
Enzo Biochem: Fiscal Q3 Earnings Snapshot
See More Headlines

ENZ Stock Analysis - Frequently Asked Questions

Enzo Biochem, Inc. (NYSE:ENZ) released its earnings results on Monday, March, 17th. The medical research company reported ($0.02) earnings per share for the quarter. The medical research company had revenue of $7.33 million for the quarter. Enzo Biochem had a negative trailing twelve-month return on equity of 7.96% and a negative net margin of 75.34%.

Enzo Biochem's top institutional shareholders include RBF Capital LLC (0.29%). Insiders that own company stock include James G Wolf and Hamid Erfanian.
View institutional ownership trends
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Enzo Biochem investors own include Zomedica (ZOM), Jumia Technologies (JMIA), Nano Dimension (NNDM), NIO (NIO), AST SpaceMobile (ASTS), Virgin Galactic (SPCE) and OneLife Technologies (OLMM).

Company Calendar

Last Earnings
3/17/2025
Today
8/22/2025
Fiscal Year End
7/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Medical laboratories
Sub-Industry
Healthcare
Current Symbol
NYSE:ENZ
CIK
316253
Employees
520
Year Founded
1976

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$26.08 million
Net Margins
-75.34%
Pretax Margin
-23.79%
Return on Equity
-7.96%
Return on Assets
-5.49%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.55
Quick Ratio
2.28

Sales & Book Value

Annual Sales
$29.09 million
Price / Sales
0.59
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.09 per share
Price / Book
0.30

Miscellaneous

Outstanding Shares
52,403,000
Free Float
46,288,000
Market Cap
$17.03 million
Optionable
Optionable
Beta
1.19

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NYSE:ENZ) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners